Longevity Health Holdings Inc. (XAGE)
Oxford Ledge is still expanding full research coverage of XAGE. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
I see you've shared an excerpt from a 10-K annual report—specifically the opening section that defines the company name change (to Longevity Health Holdings, Inc.
Source: 10-K (2025-12-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K Departure/election of directors or officers 2026-06-04
- 10-Q Quarterly financial report (unaudited) 2026-05-15
- 10-K Annual financial report with audited statements 2026-03-31
- 8-K Entry into material agreement; 3.02; Departure/election of directors or officers; Regulation FD disclosure; Financial statements and exhibits 2026-03-17
- 8-K Termination of material agreement 2025-12-12
Source: SEC EDGAR.
Annual results
5 years of annual figures for XAGE, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | $1.9M | -$6.9M | -$4.83 |
| 2024 | $50,318 | -$10.4M | -$14.56 |
| 2023 | $0 | -$15.4M | -$1.46 |
| 2022 | — | -$9.1M | -$5.47 |
| 2021 | — | -$329,382 | — |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for XAGE. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open XAGE in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.